Newlimit, founded by Coinbase Brian Armstrong

NewlylimAnd it is an emerging company aimed at increasing the period in which people can live a healthy life by programming their cells genetically, which raised a Patinian chain with $ 130 million led by Kleiner Perkins.

The new investors also invested Nat Friedman, Daniel Gross and Gosla Votshers, as well as the Fund for Returning Supporters, The dimensions of the capitalElad Gil, Garry Tan, Patrick Colison, and others. The donation collection comes two years after the company was raised Series of 40 million dollars.

Brian Armstrong, CEO of Coinbase for more than four years, and former GV partner Blake Bayers, and professor of stem cell Jacob Kimmel, claims that he has made great progress towards developing treatments that can restore the youthful characteristics of the elderly cells.

Kimmel Techcrunch told the company that the company discovered three typical drugs that reprogram liver cells. He said that the laboratory Newlimit experiences prove that this renewal can restore the ability of cells to treat fats and alcohol.

The company measures its provision by comparing how the cells respond from a smaller and elderly individual. Kimmel said that the older liver cell that passed through the re -programming of the Lagini in Neollet is behaving like the younger cell.

Despite promising early results, Newlimit is still a few years away from the start of human experiences.

Meanwhile, the company wants to continue developing new aging medicine using the artificial intelligence model and then testing the most of these drugs created by machine guns in its laboratory. Kimmel said: “What the artificial intelligence model allows us to do all of these experiments in simulation, then only follow up on a promising sub -group,” adding that the data points from the experiment are then used to re -train the artificial intelligence model in a process known as “the laboratory in a ring.”

Other startups that are worth noting in the field of biotechnology include the development of drugs that aim to increase age $ 1 billion chain A; And altos labs, which Firing With $ 3 billion in 2022 and is supported by Jeff Bezos.